Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.

Hadjibabaie M, Vazirian I, Iravani M, Moosavi SA, Alimoghaddam K, Ghavamzadeh A, Rezaee S.

Ther Drug Monit. 2011 Dec;33(6):673-80. doi: 10.1097/FTD.0b013e318235a5df.

PMID:
22011723
2.

A limited sampling strategy for the estimation of 12-hour Neoral systemic drug exposure in heart transplant recipients.

Balram C, Sivathasan C, Cheung YB, Tan SB, Tan YS.

J Heart Lung Transplant. 2002 Sep;21(9):1016-21.

PMID:
12231373
3.

Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.

Wilhelm AJ, de Graaf P, Veldkamp AI, Janssen JJ, Huijgens PC, Swart EL.

Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x.

4.

Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.

Sibbald C, Seto W, Taylor T, Saunders EF, Doyle J, Dupuis LL.

Ther Drug Monit. 2008 Aug;30(4):434-8. doi: 10.1097/FTD.0b013e318180c662.

PMID:
18641547
5.

Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.

Dupuis LL, Seto W, Teuffel O, Gibson P, Schultz KR, Doyle JD, Gassas A, Egeler RM, Sung L, Schechter T.

Biol Blood Marrow Transplant. 2013 Mar;19(3):418-23. doi: 10.1016/j.bbmt.2012.10.031.

6.

Population pharmacokinetics and Bayesian estimation of cyclosporine in a Tunisian population of hematopoietic stem cell transplant recipient.

Eljebari H, Gaies E, Fradj NB, Jebabli N, Salouage I, Trabelsi S, Lakhal M, Klouz A.

Eur J Clin Pharmacol. 2012 Nov;68(11):1517-24. doi: 10.1007/s00228-012-1275-9.

PMID:
22527344
9.

Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.

Tokui K, Kimata T, Uchida K, Yuasa H, Hayashi Y, Itatsu T, Nabeshima T.

Ther Drug Monit. 2004 Jun;26(3):287-94.

PMID:
15167630
10.
11.
12.
13.

Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.

Strong DK, Lai A, Primmett D, White CT, Lirenman DS, Carter JE, Hurley RM, Virji M, Ensom MH.

Pediatr Transplant. 2005 Oct;9(5):566-73.

PMID:
16176411
14.
15.
16.

Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.

Figurski MJ, Nawrocki A, Pescovitz MD, Bouw R, Shaw LM.

Ther Drug Monit. 2008 Aug;30(4):445-55. doi: 10.1097/FTD.0b013e318180c986.

PMID:
18641543
17.

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.

Zhao W, Fakhoury M, Baudouin V, Maisin A, DeschĂȘnes G, Jacqz-Aigrain E.

Ther Drug Monit. 2011 Dec;33(6):681-7. doi: 10.1097/FTD.0b013e318235d067.

PMID:
22011724
18.

Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.

Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH.

Transpl Int. 2002 Dec;15(12):649-54.

PMID:
12478413
19.

A limited sampling strategy for tacrolimus in renal transplant patients.

Mathew BS, Fleming DH, Jeyaseelan V, Chandy SJ, Annapandian VM, Subbanna PK, John GT.

Br J Clin Pharmacol. 2008 Oct;66(4):467-72. doi: 10.1111/j.1365-2125.2008.03251.x.

20.

Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment.

Wada K, Takada M, Kotake T, Ochi H, Morishita H, Komamura K, Oda N, Mano A, Kato TS, Hanatani A, Nakatani T.

Circ J. 2007 Jul;71(7):1022-8.

Items per page

Supplemental Content

Support Center